TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

re: Ann: VitroGro ECM CE Mark Approval Referr... I always...

  1. COLINK60
    261 Posts.
    clock Created with Sketch.
    09/08/12
    08:22
    Post #: 10545461
    re: Ann: VitroGro ECM CE Mark Approval Referr... I always thought the human trials were the biggest hurdle, but discovering very fast, that naming the product category makes human trials low risk.
    TIS Price at posting: 41.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.